---
title: "Ocular Therapeutix says FDA aligns on AXPAXLI wet AMD NDA plan for Q4 2026 submission"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290055084.md"
description: "Ocular Therapeutix has reached FDA alignment to submit a 505(b)(2) New Drug Application for AXPAXLI in wet AMD by Q4 2026. The submission will rely on SOL-1 Week 52 efficacy and safety data, supported by an interim SOL-R safety readout covering over 300 patients. SOL-R efficacy data was removed from the NDA plan, with masking extended to Week 96 and top-line results expected in Q1 2028."
datetime: "2026-06-17T12:46:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290055084.md)
  - [en](https://longbridge.com/en/news/290055084.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290055084.md)
---

# Ocular Therapeutix says FDA aligns on AXPAXLI wet AMD NDA plan for Q4 2026 submission

-   Ocular Therapeutix reached FDA alignment to file a 505(b)(2) NDA for AXPAXLI in wet AMD in 4Q 2026. \* Submission to rely on SOL-1 Week 52 efficacy and safety data, supported by an interim SOL-R safety readout to exceed 300 patients’ exposure. \* SOL-R efficacy data removed from the NDA plan; SOL-R masking extended to Week 96 with topline results expected in 1Q 2028. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [OCUL.US](https://longbridge.com/en/quote/OCUL.US.md)

## Related News & Research

- [Readystate Asset Management LP Makes New Investment in Ocular Therapeutix, Inc. $OCUL](https://longbridge.com/en/news/294190211.md)
- [Estoril Sol SGPS announces shareholder meeting](https://longbridge.com/en/news/294539397.md)
- [Estoril Sol calls annual shareholder meeting](https://longbridge.com/en/news/294243611.md)
- [Banco BPM schedules H1 2026 results presentation call](https://longbridge.com/en/news/294501538.md)
- [Kering announces availability of 2026 first-half report](https://longbridge.com/en/news/294091807.md)